Vise Technologies Inc. Takes $731,000 Position in Avantor, Inc. $AVTR

Vise Technologies Inc. purchased a new stake in Avantor, Inc. (NYSE:AVTRFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 73,825 shares of the company’s stock, valued at approximately $731,000.

A number of other institutional investors and hedge funds have also made changes to their positions in AVTR. BlackRock Inc. acquired a new stake in Avantor during the second quarter worth about $695,784,000. Wellington Management Group LLP purchased a new position in shares of Avantor in the fourth quarter valued at $268,584,000. Morgan Stanley increased its stake in Avantor by 179.4% during the 4th quarter. Morgan Stanley now owns 17,468,418 shares of the company’s stock worth $200,188,000 after buying an additional 11,216,565 shares during the period. Engine Capital Management LP increased its stake in Avantor by 65.8% during the 1st quarter. Engine Capital Management LP now owns 19,780,830 shares of the company’s stock worth $155,082,000 after buying an additional 7,853,018 shares during the period. Finally, Norges Bank acquired a new position in Avantor in the 4th quarter worth $73,322,000. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have issued reports on AVTR. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $13.00 target price on shares of Avantor in a research report on Thursday, July 30th. Wall Street Zen upgraded shares of Avantor from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. Wolfe Research raised shares of Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, July 30th. Morgan Stanley raised their price target on shares of Avantor from $10.00 to $14.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 30th. Finally, Citigroup lifted their price target on shares of Avantor from $9.00 to $11.00 and gave the company a “neutral” rating in a report on Wednesday, July 8th. Two analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Avantor presently has an average rating of “Hold” and a consensus price target of $12.00.

Read Our Latest Report on AVTR

Avantor Stock Down 0.1%

Shares of Avantor stock opened at $14.45 on Monday. The stock has a market capitalization of $9.77 billion, a price-to-earnings ratio of -17.20, a PEG ratio of 10.91 and a beta of 0.89. Avantor, Inc. has a twelve month low of $7.26 and a twelve month high of $15.93. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.65. The business’s 50 day simple moving average is $11.63 and its 200-day simple moving average is $9.64.

Avantor (NYSE:AVTRGet Free Report) last released its quarterly earnings data on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.61 billion. During the same quarter in the previous year, the firm posted $0.24 EPS. The business’s revenue for the quarter was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Equities research analysts forecast that Avantor, Inc. will post 0.81 earnings per share for the current year.

About Avantor

(Free Report)

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.

Featured Stories

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.